Citation Classic Genesis and Outcome of a Breast Cancer Trial to Develop the Aromatase Inhibitor Anastrozole

被引：1

作者：

Howell, Anthony ^{[1
]}

机构：

[1] Univ Manchester, Christie NHS Fdn Trust, Manchester Breast Ctr, Manchester M20 4BX, Lancs, England

来源：

CLINICAL CHEMISTRY | 2012年 / 58卷 / 04期

关键词：

ARIMIDEX; TAMOXIFEN;

D O I：

10.1373/clinchem.2011.181206

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：782 / 783

页数：2

共 50 条

[1] Anastrozole: A selective aromatase inhibitor for the treatment of breast cancer
Higa, GM
AlKhouri, N
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (05) : 445 - 452
[2] IBISII: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole
Cuzick, Jack
EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (09) : 1377 - 1385
[3] Focus on anastrozole: An aromatase inhibitor for the treatment of hormonally dependent advanced breast cancer
Baldinger, SL
DeFusco, P
FORMULARY, 1996, 31 (05) : 363 - &
[4] Anastrozole (arimidex®), a new aromatase inhibitor for advanced breast cancer:: Mechanism of action and role in management
Hortobagyi, GN
Buzdar, AU
CANCER INVESTIGATION, 1998, 16 (06) : 385 - 390
[5] Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer
Liu, P.
Yang, D. Q.
Xie, F.
Zhou, B.
Liu, M.
GENETICS AND MOLECULAR RESEARCH, 2014, 13 (03) : 5285 - 5291
[6] Clinical dosage determination of a new aromatase inhibitor, anastrozole, in postmenopausal Japanese women with advanced breast cancer
Nomura, Y
Koyama, H
Ohashi, Y
Watanabe, H
CLINICAL DRUG INVESTIGATION, 2000, 20 (05) : 357 - 369
[7] Anastrozole: An aromatase inhibitor as a potential preventative agent in women at high risk of developing breast cancer.
Buzdar, AU
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1245S - 1245S
[8] Clinical efficacy of the aromatase inhibitor anastrozole in relation to prolactin secretion in heavily pretreated metastatic breast cancer
Barni, S
Lissoni, P
Meregalli, S
Ardizzoia, A
Mengo, S
Musco, F
Merlini, D
Tancini, G
TUMORI, 1998, 84 (01) : 45 - 47
[9] Clinical Dosage Determination of a New Aromatase Inhibitor, Anastrozole, in Postmenopausal Japanese Women with Advanced Breast Cancer
Yasuo Nomura
Hiroki Koyama
Yasuo Ohashi
Hiroshi Watanabe
Clinical Drug Investigation, 2000, 20 : 357 - 369
[10] A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (ARIMIDEX) with megestrol acetate in postmenopausal patients with advanced breast cancer
Jonat, W
Howell, A
Blomqvist, C
Eiermann, W
Winblad, G
Tyrrell, C
Mauriac, L
Roche, H
Lundgren, S
Hellmund, R
Azab, M
EUROPEAN JOURNAL OF CANCER, 1996, 32A (03) : 404 - 412

← 1 2 3 4 5 →